The results of the evaluation of the epidemiological and economic efficiency of the immunization of the adult population with the vaccine Vaxigrip (Pasteur Mérieux Connaught, France) are presented. In accordance with the results obtained in this investigation, this vaccine was found to have pronounced epidemiological (prophylactic) efficiency and to be well tolerated. To achieve a perceptible epidemiological effect, it was sufficient to cover 43% of the group with vaccination. The economic effect of the use of Vaxigrip exceeded the costs connected with carrying out vaccination sixfold.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
evaluation epidemiological
8
epidemiological economic
8
[an evaluation
4
epidemiological
4
economic efficacy
4
efficacy immunizing
4
immunizing adults
4
adults vaxigrippe
4
vaxigrippe vaccine]
4
vaccine] evaluation
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!